Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000935836-25-000423·AYTU BIOPHARMA, INC
Schedule 13G ownership disclosure
Aytu BioPharma Inc
Common Stock · CUSIP: 054754858
Event date: 2025-06-09
- Filing-level shares
- 506,605.00
- Percent of class
- 5.6%
- LYTTON LAURENCE W
Shares: 506,605.00 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000423
- Form type
- SCHEDULE 13G
- Filer
- AYTU BIOPHARMA, INC
- CIK
- CIK 1385818
- Filed
- Jun 13, 2025
- Reporting period
- Jun 09, 2025
- Description
- Schedule 13G beneficial ownership